1.
Expert Opin Ther Pat
; 25(1): 1-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25363310
RESUMO
In the upcoming case of Teva Pharmaceuticals v. Sandoz, the U.S. Supreme Court will address how much deference the appellate court should afford to a trial court's claim construction ruling. The effect of this decision will be far-reaching, as how claims are construed can determine whether a patent is infringed or not infringed, valid or invalid.